KRAS and cancer: We identified 156 focal amplifications and 69 focal deletions, in well-known oncogenes, such as ERBB2, CCNE1, KRAS, MYC, EGFR, and CDK6, and cancer-related genes such as GATA4, GATA6, CD44 and ZNF217 (Supplementary Table S5).